Aging,
Journal Year:
2022,
Volume and Issue:
14(7), P. 3070 - 3083
Published: April 1, 2022
Alzheimer's
disease
(AD)
is
the
most
common
dementia
in
world.
Increasing
evidence
has
shown
that
exosomes
from
hypoxic
pretreated
adipose-derived
stem
cells
(ADSCs)
could
be
an
effective
cognitive
function
therapeutic
AD-associated
pathophysiology.
However,
their
role
and
regulatory
mechanism
remain
largely
unknown.
High-throughput
sequencing
was
used
to
identify
differentially
expressed
circRNAs
ADSCs
or
hypoxia
ADSC
exosomes.
Luciferase
reporter
assays
RT-qPCR
were
investigate
relationships
between
circ-Epc1,
miR-770-3p,
TREM2.
APP/PS1
double
transgenic
AD
model
mice
then
study
effects
regarding
circ-Epc1
BV2
show
TREM2
how
these
interactions
modulated
phenotypic
transformations
inflammatory
cytokine
expressions
microglia.
The
results
showed
had
a
good
effect
on
improving
functions
by
decreasing
neuronal
damage
hippocampus.
played
important
hypoxia-pretreated
ability
improve
functions.
miR-770-3p
downstream
targets
of
circ-Epc1.
Overexpressing
downregulating
reversed
M2
microglia
during
lipopolysaccharide
treatment.
In
vivo
experiments
circ-Epc1-containing
increased
function,
damage,
shifting
hippocampal
M1
polarization
stages.
Taken
together,
data
pretreatment
improved
cognition
delivery
microglial
M1/M2
mouse
model.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Dec. 16, 2022
Aging
is
a
gradual
and
irreversible
pathophysiological
process.
It
presents
with
declines
in
tissue
cell
functions
significant
increases
the
risks
of
various
aging-related
diseases,
including
neurodegenerative
cardiovascular
metabolic
musculoskeletal
immune
system
diseases.
Although
development
modern
medicine
has
promoted
human
health
greatly
extended
life
expectancy,
aging
society,
variety
chronic
diseases
have
gradually
become
most
important
causes
disability
death
elderly
individuals.
Current
research
on
focuses
elucidating
how
endogenous
exogenous
stresses
(such
as
genomic
instability,
telomere
dysfunction,
epigenetic
alterations,
loss
proteostasis,
compromise
autophagy,
mitochondrial
cellular
senescence,
stem
exhaustion,
altered
intercellular
communication,
deregulated
nutrient
sensing)
participate
regulation
aging.
Furthermore,
thorough
pathogenesis
to
identify
interventions
that
promote
longevity
caloric
restriction,
microbiota
transplantation,
nutritional
intervention)
clinical
treatment
methods
for
(depletion
senescent
cells,
therapy,
antioxidative
anti-inflammatory
treatments,
hormone
replacement
therapy)
could
decrease
incidence
turn
healthy
longevity.
Frontiers in Genetics,
Journal Year:
2019,
Volume and Issue:
10
Published: March 1, 2019
Alzheimer's
Disease
(AD)
is
a
progressive
and
devastating
neurodegenerative
disorder.
It
the
leading
cause
of
dementia
in
world's
rapidly
growing
aging
population.
The
characteristics
AD
are
memory
loss
cognitive
impairment,
meaning
patients
cannot
carry
out
their
daily
activities
independently.
increase
cases
poses
heavy
burdens
on
families,
society
economy.
Despite
frequent
efforts
being
made
to
research
etiology
AD,
causes
remain
unknown,
no
curative
treatments
available
yet.
pathological
hallmarks
amyloid
plaques
neurofibrillary
tangles
brain;
microRNAs
endogenous
~22
nucleotides
non-coding
RNAs
that
could
regulate
gene
expression
at
post-transcriptional
level
by
transcript
degradation
or
translation
repression.
involved
many
biological
processes
diseases,
particularly
multifactorial
providing
an
excellent
tool
with
which
mechanisms
these
diseases.
disorder,
accumulating
evidence
shows
play
critical
role
pathogenesis
AD.
In
this
review,
we
will
highlight
effect
different
throughout
progression.
Clinical Anatomy,
Journal Year:
2021,
Volume and Issue:
35(1), P. 65 - 78
Published: Sept. 24, 2021
Neurodegenerative
disorders
are
characterized
by
progressive
loss
of
particular
populations
neurons.
Apoptosis
has
been
implicated
in
the
pathogenesis
neurodegenerative
diseases,
including
Parkinson
disease,
Alzheimer
Huntington
and
amyotrophic
lateral
sclerosis.
In
this
review,
we
focus
on
existing
notions
relevant
to
comprehending
apoptotic
death
process,
morphological
features,
mediators
regulators
cellular
apoptosis.
We
also
highlight
evidence
neuronal
Additionally,
present
potential
therapeutic
agents
that
could
modify
pathway
aforementioned
diseases
delay
disease
progression.
Finally,
review
clinical
trials
were
conducted
evaluate
use
anti-apoptotic
drugs
treatment
order
essential
need
for
early
detection
intervention
humans.
Molecular Therapy,
Journal Year:
2023,
Volume and Issue:
31(6), P. 1550 - 1561
Published: Feb. 14, 2023
Investigation
of
lncRNA
functions
in
the
CNS
is
a
rapidly
expanding
field
that
holds
exciting
potential
for
new
advances
understanding
brain
cell
physiology
and
improving
disease
diagnosis
therapy.
This
review
summarizes
important
evidence
regarding
roles
lncRNAs
cellular
molecular
processes,
highlighting
few
have
been
studied
as
biomarkers
disorders
involving
neurodegeneration,
neurodevelopment,
more.
Our
current
fine-tuning
influence
variety
human
diseases
represent
type
molecule
can
be
easily
targeted
with
high
specificity.
However,
direct
involvement
pathologies
has
shown
only
reduced
number
cases.
Given
tissues
exhibit
large
enrichment
diversity
ncRNAs,
future
research
will
key
to
elucidating
known
still
unidentified
CNS,
these
noncodings
serve
diagnostic
even
targets
treatment
conditions.
Translational Neurodegeneration,
Journal Year:
2024,
Volume and Issue:
13(1)
Published: Jan. 23, 2024
Abstract
Ageing
is
a
crucial
risk
factor
for
Alzheimer’s
disease
(AD)
and
characterised
by
systemic
changes
in
both
intracellular
extracellular
microenvironments
that
affect
the
entire
body
instead
of
single
organ.
Understanding
specific
mechanisms
underlying
role
ageing
development
can
facilitate
treatment
ageing-related
diseases,
such
as
AD.
Signs
brain
have
been
observed
AD
patients
animal
models.
Alleviating
pathological
caused
dramatically
ameliorate
amyloid
beta-
tau-induced
neuropathological
memory
impairments,
indicating
plays
pathophysiological
process
In
this
review,
we
summarize
impact
several
age-related
factors
on
propose
preventing
promising
strategy
improving
cognitive
health.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
176, P. 116836 - 116836
Published: June 7, 2024
Alzheimer's
disease
(AD)
is
a
devastating
neurological
condition
characterized
by
cognitive
decline,
motor
coordination
impairment,
and
amyloid
plaque
accumulation.The
underlying
molecular
mechanisms
involve
oxidative
stress,
inflammation,
neuronal
degeneration.This
study
aimed
to
investigate
the
therapeutic
Acta Neuropathologica,
Journal Year:
2018,
Volume and Issue:
136(4), P. 537 - 555
Published: July 7, 2018
MicroRNAs
(miRNA)
regulate
fundamental
biological
processes,
including
neuronal
plasticity,
stress
response,
and
survival.
Here,
we
describe
a
neuroprotective
function
of
miR-132,
the
miRNA
most
significantly
downregulated
in
neurons
Alzheimer's
disease.
We
demonstrate
that
miR-132
protects
primary
mouse
human
wild-type
more
vulnerable
Tau-mutant
against
amyloid
β-peptide
(Aβ)
glutamate
excitotoxicity.
It
lowers
levels
total,
phosphorylated,
acetylated,
cleaved
forms
Tau
implicated
tauopathies,
promotes
neurite
elongation
branching,
reduces
death.
Similarly,
attenuates
PHF-Tau
pathology
neurodegeneration,
enhances
long-term
potentiation
P301S
transgenic
mice.
The
effects
are
mediated
by
direct
regulation
modifiers
acetyltransferase
EP300,
kinase
GSK3β,
RNA-binding
protein
Rbfox1,
proteases
Calpain
2
Caspases
3/7.
These
data
suggest
as
master
regulator
health
indicate
supplementation
could
be
therapeutic
benefit
for
treatment
Tau-associated
neurodegenerative
disorders.
Nucleic Acids Research,
Journal Year:
2020,
Volume and Issue:
49(D1), P. D160 - D164
Published: Aug. 14, 2020
Many
studies
have
indicated
that
non-coding
RNA
(ncRNA)
dysfunction
is
closely
related
to
numerous
diseases.
Recently,
accumulated
ncRNA-disease
associations
made
databases
insufficient
meet
the
demands
of
biomedical
research.
The
constant
updating
resources
has
become
essential.
Here,
we
updated
mammal
repository
(MNDR,
http://www.rna-society.org/mndr/)
version
3.0,
containing
more
than
one
million
entries,
four-fold
increment
in
data
compared
previous
version.
Experimental
and
predicted
circRNA-disease
been
integrated,
increasing
number
categories
ncRNAs
five,
mammalian
species
11.
Moreover,
drug
annotations
associations,
as
well
ncRNA
subcellular
localizations
interactions,
were
added.
In
addition,
three
(miRNA/lncRNA/circRNA)
prediction
tools
provided,
website
was
also
optimized,
making
it
practical
user-friendly.
summary,
MNDR
v3.0
will
be
a
valuable
resource
for
investigation
disease
mechanisms
clinical
treatment
strategies.